White Papers
-
Empowering Transformation Through Technology
4/24/2024
By outlining the transformation of clinical data management into data science, this paper highlights the growing responsibility of data managers as stewards of all clinical trial data and its overall quality.
-
Considerations For Plain Language Summaries
4/22/2024
Recent FDA emphasis on plain language underscores a shift towards greater transparency and patient understanding, highlighted in the joint FDA and Office for Human Research Protections (OHRP) draft guidance.
-
Optimizing Generative AI In Clinical Operations
4/17/2024
Crafting a thoughtful strategy to determine the optimal utilization of Generative AI in advancing medical research and enhancing patient well-being.
-
Patient-Defined Recruitment: The Movement Advanced By COVID-19
4/17/2024
The pandemic forced the pharmaceutical industry to reimagine how we recruit patients to clinical trials – and it's delivering significant benefits to sponsors who embrace these changes.
-
How Clinical Trial Design Impacts Enrollment Of Diverse Populations
4/17/2024
Discover the latest findings revealing crucial insights into the factors influencing participants' engagement in clinical trials, offering valuable knowledge about the diverse perspectives and considerations driving participation decisions.
-
Insights: Global Patient Views And Engagement In Clinical Trials
4/15/2024
Enhancing the patient journey within clinical trials begins with engaging participants to understand their needs and preferences, ensuring they enroll and remain committed throughout the study.
-
Patient Diversity: Identifying Challenges, Opportunities, And Best Practices
4/10/2024
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
Cystic Fibrosis: Global Clinical Trial Landscape (2024)
4/8/2024
Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.
-
Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)
4/8/2024
Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
-
Digital Biomarker Upholds Adherence, User Satisfaction, Validity
3/25/2024
Clinical outcome assessments can present challenges in clinical trials. Discover how this solution is able to utilize digital biomarkers to identify and measure clinically relevant signals in neurological conditions.